Suppr超能文献

弥漫表达甲状腺转录因子-1 和 ΔNp63/p40 的非小细胞肺癌。

Non-small cell lung carcinoma with diffuse coexpression of thyroid transcription factor-1 and ΔNp63/p40.

机构信息

Department of Human Pathology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

出版信息

Hum Pathol. 2018 Aug;78:177-181. doi: 10.1016/j.humpath.2018.01.023. Epub 2018 Feb 2.

Abstract

Here, we present a case of non-small cell lung carcinoma (NSCLC) with widespread and strong nuclear immunopositivity for both thyroid transcription factor-1 (TTF-1) and ΔNp63/p40 (p40). Double immunofluorescence for TTF-1 and p40 showed coexpression of both markers in the tumor cells. Furthermore, PTEN (pHis123Asp) and TP53 (pVal272Leu) mutations were identified as possible mitogenic driver mutations by next-generation sequencing. To the best of our knowledge, this is the first case of NSCLC harboring concurrent PTEN and TP53 mutations with widespread and strong coexpression of TTF-1 and p40, which has been confirmed in the resected specimen, and only the second documented case of NSCLC with TTF-1 and p40 diffuse coexpression in the carcinoma cells from the same individual. Our case illustrates the possibility that poorly differentiated NSCLCs with widespread and strong nuclear positivity for TTF-1 and p40 may be an underrecognized and new entity.

摘要

在这里,我们报告了一例非小细胞肺癌(NSCLC)病例,该病例的甲状腺转录因子-1(TTF-1)和 ΔNp63/p40(p40)均广泛且强烈呈核免疫阳性。TTF-1 和 p40 的双重免疫荧光显示肿瘤细胞中两种标志物的共表达。此外,通过下一代测序鉴定出 PTEN(pHis123Asp)和 TP53(pVal272Leu)突变可能是有丝分裂驱动突变。据我们所知,这是首例在切除标本中证实存在同时伴有 PTEN 和 TP53 突变且 TTF-1 和 p40 广泛且强烈共表达的 NSCLC,并且是第二例在同一患者的癌细胞中存在 TTF-1 和 p40 弥漫性共表达的 NSCLC 病例。我们的病例说明了一种可能性,即广泛且强烈表达 TTF-1 和 p40 的低分化 NSCLC 可能是一种认识不足的新型实体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验